The Business Times
business-time-50
SUBSCRIBERS

Temasek leads US$85m investment round for gene therapy startup

google-preferred-sourceAdd BT as a preferred source
Published Tue, Feb 26, 2019 · 09:50 PM

Singapore

IMMUNE cell gene therapy startup Gracell Biotechnologies has raised US$85 million through a Series B round led by Singapore government investment firm Temasek Holdings.

Also taking part in the financing round were Lilly Asia Ventures, Kington Capital, King Star Capital and Chengdu Miaoji.

Temasek

TRENDING NOW

Siranudh Scott had caused an internet sensation with a video accusing his brother of allegedly abusing him during his childhood years.

‘I felt like dying’: Thai Singha beer scion speaks up after disclosure of alleged sexual abuse

Assets under management of physical gold holdings in DBS wealth clients’ portfolios more than doubled over the past three years.

DBS to launch tokenised physical gold for retail customers in Singapore

As with past tranches, the S$500 will be split equally between participating heartland merchants and hawkers, and participating supermarkets.

S$500 CDC vouchers for all Singaporean households from June 11; Government ready to do more if needed: DPM Gan

MenToo’s launch at Timbre+ One North brought together 12 men’s groups to discuss men’s mental health and masculinity in Singapore.

Singapore men, are you OK?

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More